发明名称 PEPTIDE KETONES, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF INTERLEUKIN-1beta PROTEASE ACTIVITY
摘要 FIELD: organic chemistry, medicine, pharmacy. SUBSTANCE: invention relates to peptide ketones of the formula (I) 1beta or their pharmaceutically acceptable salt where <EMI ID=0.76 HE=24 WI=78 TI=CHI> - H, halogen atom, lower alkyl, phenyl or benzyl; R<SB>2</SB> and R<SB>3</SB> - H or lower alkyl; A is D- or L-isomer of amino acid (valine or alanine); Z is R<SB>4</SB> or O; n = 0-2, and pharmaceutical compositions on their basis showing the selective inhibition of an enzyme that converts an interleukin-CH<SB>2</SB> and can be benefit for treatment of patients with inflammatory, immune diseases and cancer. EFFECT: curative effect of compounds and compositions. 15 cl, 15 ex
申请公布号 RU2133251(C1) 申请公布日期 1999.07.20
申请号 RU19940015842 申请日期 1994.05.06
申请人 VERTEKS FARMAS'JUTIKALZ INKORPOREJTED 发明人 ROLAND I.DOLLI;TODD L.GREJBILL;GEHRI DZH.SPEJR;KEHTERIN P.PROUTI;STEJNLI DZH.SHMIDT
分类号 A61K31/195;A61K31/198;A61K31/215;A61K31/365;A61K38/00;A61K38/06;A61P29/00;A61P35/00;A61P37/00;A61P43/00;C07C233/47;C07C233/83;C07C271/22;C07C323/58;C07D307/60;C07K5/02;C07K5/04;C07K5/06;C07K5/08;C07K5/10;C07K5/103;C07K14/81;(IPC1-7):C07K5/103 主分类号 A61K31/195
代理机构 代理人
主权项
地址